NBE-Therapeutics awarded second CHF 1.0 mio CTI grant

NBE-Therapeutics has received a second CHF 1.0 mio grant for a three-year R&D collaboration with the group of Prof. Georg Lipps at the Technical University of Life Sciences, North-Western Switzerland (FHNW, Fachhochschule Nordwestschweiz). The R&D collaboration is focused at developing additional novel approaches to enzymatically conjugate payloads to antibodies. This will extend and diversify the site-specific conjugation technologies of NBE-Therapeutics for the generation of "next-generation" antibody drug conjugates (ADCs).